Cannabinoid modulation of electrically evoked pH and oxygen transients in the nucleus accumbens of awake rats

Journal of Neurochemistry

Volumn 97, Issue 4, 2006, Pages 1145-1154

  Cheer, Joseph F ^a   Wassum, Kate M ^a   Wightman, R Mark ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Blood flow and metabolism; Cannabinoids; Cyclic voltammetry; Dopamine; Nucleus accumbens

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CARBON FIBER; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NIMODIPINE; OXYGEN; RIMONABANT; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN METABOLISM; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; ELECTROSTIMULATION; EVOKED RESPONSE; GENE EXPRESSION; MALE; MEDIAL FOREBRAIN BUNDLE; MICROELECTRODE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; OXYGEN TRANSPORT; PH; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; STIMULUS RESPONSE; WAKEFULNESS;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CEREBROVASCULAR CIRCULATION; ELECTRIC STIMULATION; ENERGY METABOLISM; HYDROGEN-ION CONCENTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; MORPHOLINES; NAPHTHALENES; NUCLEUS ACCUMBENS; OXYGEN CONSUMPTION; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1;

ANIMALIA;

EID: 33646096728     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03860.x     Document Type: Article

References (46)

1. Cheer J. F. Wassum K. M. Heien M. L. Phillips P. E. Wightman R. M. 2004 Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J. Neurosci. 24 4393 4400.
2. Chen Y. McCarron R. M. Ohara Y. Bembry J. Azzam N. Lenz F. A. Shohami E. Mechoulam R. Spatz M. 2000 Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ. Res. 87 323 327.
3. Chesler M. 2003 Regulation and modulation of pH in the brain. Physiol. Rev. 83 1183 1221.
4. Di Marzo V. Hill M. P. Bisogno T. Crossman A. R. Brotchie J. M. 2000 Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB. J. 14 1432 1438.
5. Di Marzo V. Bifulco M. De Petrocellis L. 2004 The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3 771 784.
6. Ellis E. F. Moore S. F. Willoughby K. A. 1995 Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol. 269 1859 1864.
7. Fray A. E. Forsyth R. J. Boutelle M. G. Fillenz M. 1996 The mechanisms controlling physiologically stimulated changes in rat brain glucose and lactate: a microdialysis study. J. Physiol. 496 49 57.
8. Freundt T. F. Katona I. Piomelli D. 2003 Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 1017 1066.
9. Gardiner S. M. March J. E. Kemp P. A. Bennett T. 2001 Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats. Br. J. Pharmacol. 133 445 453.
10. 1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am. J. Physiol. 276 H2085 H2093.
11. Giuffrida A. Parsons L. H. Kerr T. M. Rodriguez de Fonseca F. Navarro M. Piomelli D. 1999 Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2 358 363.
12. Hajos N. Ledent C. Freund T. F. 2001 Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 1 4.
13. Heien M. L. Phillips P. E. Stuber G. D. Seipel A. T. Wightman R. M. 2003 Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst 128 1413 1419.
14. Hillard C. J. 2000 Endocannabinoids and vascular function. J. Pharmacol. Exp. Ther. 294 27 32.
15. Högestatt E. D. Zygmunt P. M. 2002 Cardiovascular pharmacology of anandamide. Prostaglandins Leukot. Essent. Fatty Acids 66 343 351.
16. Jones R. T. 2002 Cardiovascular system effects of marijuana. J. Clin. Pharmacol. 42 58S 63S.
17. Julian M. D. Martin A. B. Cuellar B. Rodriguez De Fonseca F. Navarro M. Moratalla R. Garcia-Segura L. M. 2003 Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 119 309 318.
18. Kilpatrick M. R. Rooney M. B. Michael D. J. Wightman R. M. 2000 Extracellular dopamine dynamics in rat caudate-putamen during experimenter-delivered and intracranial self-stimulation. Neuroscience 96 697 706.
19. Krimer L. S. Muly E. C. 3rd Williams G. V. Goldman-Rakic P. S. 1998 Dopaminergic regulation of cerebral cortical microcirculation. Nat. Neurosci. 1 286 289.
20. Lavyne M. H. Koltun W. A. Clement J. A. Rosene D. L. Pickren K. S. Zervas N. T. Wurtman R. J. 1977 Decrease in neostriatal blood flow after d -amphetamine administration or electrical stimulation of the substantia nigra. Brain. Res. 135 77 86.
21. Ligresti A. Morera E. Van Der Stelt M. Monory K. Lutz B. Ortar G. Di Marzo V. 2004 Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem. J. 380 265 272.
22. Lowry J. P. Boutelle M. G. Fillenz M. 1997 Measurement of brain tissue oxygen at a carbon past electrode can serve as an index of increases in regional cerebral blood flow. J. Neurosci. Meth. 71 177 182.
23. Lupica C. R. Riegel A. C. Hoffman A. F. 2004 Marijuana and cannabinoid regulation of brain reward circuits. Br. J. Pharmacol. 143 227 234.
24. Mathew R. J. Wilson W. H. 1993 Acute changes in cerebral blood flow after smoking marijuana. Life Sci. 52 757 767.
25. Michael D. Travis E. R. Wightman R. M. 1998 Color images for fast-scan CV measurements in biological systems. Anal. Chem. 70 586A 592A.
26. Mohamed A. A. Gotoh O. Graham D. I. Osborne K. A. McCulloch J. Mendelow A. D. Teasdale G. M. Harper A. M. 1985 Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann. Neurol. 18 705 711.
27. Nieuwenhuys R. Geeraedts L. M. Veening J. G. 1982 The medial forebrain bundle of the rat. I. General introduction. J. Comp. Neurol. 206 49 81.
28. Patel S. Rademacher D. J. Hillard C. J. 2003 Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J. Pharmacol. Exp. Ther. 306 880 888.
29. Paxinos G. Watson C. 1986 The Rat Brain in Stereotaxic Coordinates. Academic Press New York.
30. Pfitzer T. Niederhoffer N. Szabo B. 2004 Central effects of the cannabinoid receptor agonist WIN55212-2 on respiratory and cardiovascular regulation in anaesthetised rats. Br. J. Pharmacol. 142 943 952.
31. Raichle M. E. 1998 Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc. Natl Acad. Sci. USA 95 765 772.
32. Randall M. D. Harris D. Kendall D. A. Ralevic V. 2002 Cardiovascular effects of cannabinoids. Pharmacol. Ther. 295 191 202.
33. Randall M. D. Kendall D. A. O'Sullivan S. 2004 The complexities of the cardiovascular actions of cannabinoids. Br. J. Pharmacol. 142 20 26.
34. Roitman M. F. Stuber G. D. Phillips P. E. M. Wightman R. M. Carelli R. M. 2004 Dopamine operates as a subsecond modulator of food seeking. J. Neurosci. 24 1265 1271.
35. Runnels P. L. Joseph J. D. Logman M. J. Wightman R. M. 1999 Effect of pH and surface functionalities on the cyclic voltammetric responses of carbon-filter microelectrodes. Anal. Chem. 71 2782 2789.
36. Snyder S. H. 1971 Uses of Marijuana. Oxford University Press
37. 1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243 838 843.
38. Twitchell W. Brown S. Mackie K. 1997 Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78 43 50.
39. Venton B. J. Michael D. J. Wightman R. M. 2003 Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J. Neurochem. 84 373 381.
40. 1 receptors. Eur. J. Pharmacol. 423 203 210.
41. White R. Ho W. S. Bottrill F. E. Ford W. R. Hiley C. R. 2001 Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br. J. Pharmacol. 134 921 929.
42. Wilson R. I. Nicoll R. A. 2002 Endocannabinoid signaling in the brain. Science 296 678 682.
43. Yanpallewar S. U. Hota D. Rai S. Kumar M. Acharya S. B. 2004 Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats. Pharmacol. Res. 49 143 150.
44. Zimmerman J. B. Wightman R. M. 1991 Simultaneous electrochemical measurements of oxygen and dopamine in vivo. Anal. Chem. 63 24 28.
45. Zimmerman J. B. Kennedy R. T. Wightman R. M. 1992 Evoked neuronal activity accompanied by transmitter release increases oxygen concentration in rat striatum in vivo but not in vitro. J. Cereb. Blood Flow Metab. 12 629 637.
46. Zygmunt P. M. Chuang H. H. Movahed P. Julius D. Högestatt E. D. 2000 The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur. J. Pharmacol. 396 39 42.